Early career research fuels diagnostic discovery
Ph.D. candidate Kenneth Riley has developed a new technology that could detect cancer by analyzing a patient’s blood sample.
Ph.D. candidate Kenneth Riley has developed a new technology that could detect cancer by analyzing a patient’s blood sample.
Hear from three OHSU Doernbecher Children’s Hospital providers from a variety of specialties for insight into the vital and life-saving importance of pediatric research.
The Knight Cancer Institute and CEDAR have recruited, organized and empowered dozens of brilliant, passionate people from radically different scientific backgrounds to come together around a common goal and solve complex problems. Meet eight scientists who are bringing early cancer detection into a new era.
Ngo’s work involves analyzing blood samples for signs of early disease, aiming to detect signals from the body that mark transitions from healthy to cancerous states.
Rames’ work with microscopy and imaging technologies allows him to look at cellular structures like mitochondria and the ways they’re impacted by cancer.
Song specializes in machine learning and AI, applying them to biomedical data, especially images focusing on cancer.
Ekşi and her team investigate how interactions between nerves and cancer happen at the molecular level, with the goal of preventing it.
Bertassoni leads a multidisciplinary research group working on several groundbreaking uses of biofabrication to study cancer, including 3D bioprinting, organs-on-a-chip, and stem cell regenerative medicine.
Moreau’s lab has found promising research on a type of immune cell, the memory B cell, that could act as a therapeutic target for cancer.
Franca is a core faculty member in the Knight Cancer Precision Biofabrication Hub, recreating environments on-a-chip to study epithelial cancer development.